Onconetix, Inc. — Director's Dealing 2022

Nov 9, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Blue Water Vaccines Inc. (BWV)
CIK: 0001782107
Period of Report: 2022-11-08

Reporting Person: Jeremic Vuk (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-11-08	Stock Option	$1.06	A	3610	Acquired	2032-11-07	Common Stock (3610)	Direct

Footnotes

F1: Stock options (the "Options") were granted to Mr. Jeremic on November 8, 2022. The Options vest and become exercisable in 6 equal monthly installments beginning on December 8, 2022 and ending on May 31, 2023.